RT Journal Article
SR Electronic
T1 Similar viral loads in Omicron infections regardless of vaccination status
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.19.22274005
DO 10.1101/2022.04.19.22274005
A1 Hirotsu, Yosuke
A1 Maejima, Makoto
A1 Shibusawa, Masahiro
A1 Natori, Yume
A1 Nagakubo, Yuki
A1 Hosaka, Kazuhiro
A1 Sueki, Hitomi
A1 Mochizuki, Hitoshi
A1 Tsutsui, Toshiharu
A1 Kakizaki, Yumiko
A1 Miyashita, Yoshihiro
A1 Omata, Masao
YR 2022
UL http://medrxiv.org/content/early/2022/04/19/2022.04.19.22274005.abstract
AB Background Although SARS-CoV-2 booster vaccinations are underway, breakthrough infections with Omicron variants are occurring. This study analyzed associations between Omicron sublineage (BA.1.1 and BA.2) viral load and vaccination history.Methods Viral loads in nasopharyngeal swabs were evaluated by quantitative real-time PCR, and the virus strain was evaluated by whole-genome analysis or TaqMan assay.Results A total of 611 patients positive for an Omicron SARS-CoV-2 variant were included; 199 were unvaccinated, 370 had received two vaccine doses, and 42 had received three doses. Similar viral loads and Ct values of BA.1.1 and BA.2 were detected regardless of vaccination history. No correlations between age and BA.1.1 and BA.2 viral load were observed.Conclusion Omicron-infected patients who had received a third vaccine dose had viral loads similar to patients with two doses or who were unvaccinated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a Grant-in-Aid for the Genome Research Project from Yamanashi Prefecture (to M.O. and Y.H.), the Japan Society for the Promotion of Science KAKENHI Early-Career Scientists JP18K16292 (to Y.H.), a Grant-in-Aid for Scientific Research (B) 20H03668 (to Y.H.), a Research Grant for Young Scholars (to Y.H.), the YASUDA Medical Foundation (to Y.H.), the Uehara Memorial Foundation (to Y.H.), and medical research grants from the Takeda Science Foundation (to Y.H.).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the Clinical Research and Genome Research Committee at Yamanashi Central Hospital approved this study and the use of an opt-out consent method (Approval No. C2019-30). The requirement for written informed consent was waived because this was an observational study and there is an urgent need to collect COVID-19 data.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors